Interestingly, previous studies showed that reduced CD9 expression in primary tumor tissue was linked to poorer prognosis in CRC (Mori et al., 1998; Kim et al., 2016), while increased CD9 expression inhibited colon carcinoma cell growth (Ovalle et al., 2007). This evidence concerns the gene CD9 and colorectal carcinoma.